FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dario Neri

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Devices

Drug Delivery Systems

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Derrek A Heuveling; Otto S Hoekstra; Marc C Huisman; C René Leemans; Dario Neri; Remco de Bree; Leonardo Giovannoni; Danielle J Vugts; Guus A M S van Dongen
Phase 0 microdosing PET study using the human mini antibody F16SIP in head and neck cancer patients.
Gianluca Spitaleri; A Tasciotti; R Berardi; T De Pas; L Giovannoni; Reinerio González-Iglesias; C Libbra; Hans D Menssen; Dario Neri; Cristina Noberasco; C Pierantoni; Filippo de Braud
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.
Martina Steiner; Katrin Gutbrodt; Nikolaus Krall; Dario Neri
Tumor-targeting antibody-anticalin fusion proteins for in vivo pretargeting applications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dario Neri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Derrek A Heuveling; Otto S Hoekstra; Marc C Huisman; C René Leemans; Dario Neri; Remco de Bree; Leonardo Giovannoni; Danielle J Vugts; Guus A M S van Dongen
Phase 0 microdosing PET study using the human mini antibody F16SIP in head and neck cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(3):397-401.
2013: Gianluca Spitaleri; A Tasciotti; R Berardi; T De Pas; L Giovannoni; Reinerio González-Iglesias; C Libbra; Hans D Menssen; Dario Neri; Cristina Noberasco; C Pierantoni; Filippo de Braud
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.
Journal of cancer research and clinical oncology 2013;139(3):447-55.
2013: Martina Steiner; Katrin Gutbrodt; Nikolaus Krall; Dario Neri
Tumor-targeting antibody-anticalin fusion proteins for in vivo pretargeting applications.
Bioconjugate chemistry 2013;24(2):234-41.
2013: Francesco Papadia; Roberto Patuzzo; mario santinami; Annaelisa Tasciotti; Elisa Ventura; Luciano Zardi; Annabella Di Florio; Leonardo Giovannoni; Reinerio González-Iglesias; Valeria Lovato; Andrea Maurichi; Hans D Menssen; Dario Neri; Valeria Basso; Franco De Cian
Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma.
Journal of surgical oncology 2013;107(2):173-9.
2013: Nikolaus Krall; Jörg Scheuermann; Dario Neri
Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries.
Angewandte Chemie (International ed. in English) 2013;52(5):1384-402.
2012: Teresa Hemmerle; Sarah Wulhfard; Dario Neri
A critical evaluation of the tumor-targeting properties of bispecific antibodies based on quantitative biodistribution data.
Protein engineering, design & selection : PEDS 2012;25(12):851-4.
2012: Nadine Pasche; Francesca Pretto; Sarah Wulhfard; Elisa Carugati; Dario Neri
The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(15):4092-103.
2012: Giulio Casi; Dario Neri
Antibody-drug conjugates: basic concepts, examples and future perspectives.
Journal of controlled release : official journal of the Controlled Release Society 2012;161(2):422-8.
2012: Kathrin Zuberbühler; Gonçalo J L Bernardes; Giulio Casi; Dario Neri
Fucose-specific conjugation of hydrazide derivatives to a vascular-targeting monoclonal antibody in IgG format.
Chemical communications (Cambridge, England) 2012;48(56):7100-2.
2012: Markus Leimbacher; Luca Mannocci; Tim Geppert; Jörg Scheuermann; Gisbert Schneider; Michael Stravs; Yixin Zhang; Dario Neri
Discovery of small-molecule interleukin-2 inhibitors from a DNA-encoded chemical library.
Chemistry (Weinheim an der Bergstrasse, Germany) 2012;18(25):7729-37.
2012: Nadine Pasche; Dario Neri
Immunocytokines: a novel class of potent armed antibodies.
Drug discovery today 2012;17(11-12):583-90.
2012: Giulio Casi; Nicolas Huguenin-Dezot; Jörg Scheuermann; Kathrin Zuberbühler; Dario Neri
Site-specific traceless coupling of potent cytotoxic drugs to recombinant antibodies for pharmacodelivery.
Journal of the American Chemical Society 2012;134(13):5887-92.
2012: Nadine Pasche; Katharina Frey; Dario Neri
The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate.
Angiogenesis 2012;15(1):165-9.
2012: Gonçalo J L Bernardes; Giulio Casi; Isabelle Hartmann; Jörg Scheuermann; Kathrin Schwager; Sabrina Trüssel; Dario Neri
A traceless vascular-targeting antibody-drug conjugate for cancer therapy.
Angewandte Chemie (International ed. in English) 2012;51(4):941-4.
2011: Martina Steiner; Dario Neri
Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(20):6406-16.
2011: Dario Neri; Claudiu T Supuran
Interfering with pH regulation in tumours as a therapeutic strategy.
Nature reviews. Drug discovery 2011;10(10):767-77.
2011: Kathrin Schwager; Eveline Trachsel; Frank Bootz; Patrick Imesch; Manuela Kaspar; Dario Neri
The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.
Human reproduction (Oxford, England) 2011;26(9):2344-52.
2011: Katharina Frey; Dario Neri; Kathrin Schwager; Marjam J Barysch; Benedetta Belloni; Michael Fiechter; Reinhard Dummer
Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions.
Experimental dermatology 2011;20(8):685-8.
2011: Nadine Pasche; Janine Woytschak; Sarah Wulhfard; Alessandra Villa; Katharina Frey; Dario Neri
Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7.
Journal of biotechnology 2011;154(1):84-92.
2011: Alessandra Villa; Sarah Wulhfard; Emil Bujak; Valeria Lovato; Nadine Pasche; Dario Neri
A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin.
mAbs 2011;3(3):264-72.
2011: Fabian Buller; Martina Steiner; Katharina Frey; Dennis Mircsof; Jörg Scheuermann; Markus Kalisch; Peter Buhlmann; Claudiu T Supuran; Dario Neri
Selection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds.
ACS chemical biology 2011;6(4):336-44.
2011: Christoph Roesli; Tim Fugmann; Beatrice Borgia; Christoph Schliemann; Dario Neri; Mathias Jucker
The accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosis.
Journal of proteomics 2011;74(4):539-46.
2011: Katharina Frey; Andjelija Zivanovic; Kathrin Schwager; Dario Neri
Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation.
Integrative biology : quantitative biosciences from nano to macro 2011;3(4):468-78.
2011: A Palumbo; F Hauler; P Dziunycz; K Schwager; A Soltermann; F Pretto; C Alonso; Günther Hofbauer; Ross W Boyle; Dario Neri
A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels.
British journal of cancer 2011;104(7):1106-15.
2011: Michael Fiechter; Katharina Frey; Tim Fugmann; Philipp A Kaufmann; Dario Neri
Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies.
Atherosclerosis 2011;214(2):325-30.
2010: Katharina Frey; Christoph Schliemann; Kathrin Schwager; Raffaella Giavazzi; Manfred Johannsen; Dario Neri
The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma.
The Journal of urology 2010;184(6):2540-8.
2010: Viviane Mumprecht; Michael Honer; Benjamin Vigl; Steven T Proulx; Eveline Trachsel; Manuela Kaspar; Nadja E Banziger-Tobler; Roger Schibli; Dario Neri; Michael Detmar
In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
Cancer research 2010;70(21):8842-51.
2010: Luca Mannocci; Samu Melkko; Fabian Buller; Ilona Molnàr; Jean-Paul Gapian Bianké; Christoph E Dumelin; Jörg Scheuermann; Dario Neri
Isolation of potent and specific trypsin inhibitors from a DNA-encoded chemical library.
Bioconjugate chemistry 2010;21(10):1836-41.
2010: Christoph Roesli; Dario Neri
Methods for the identification of vascular markers in health and disease: from the bench to the clinic.
Journal of proteomics 2010;73(11):2219-29.
2010: Verena Strassberger; Sabrina Trüssel; Tim Fugmann; Dario Neri; Christoph Roesli
A novel reactive ester derivative of biotin with reduced membrane permeability for in vivo biotinylation experiments.
Proteomics 2010;10(19):3544-8.
2010: Fabian Buller; Luca Mannocci; Jörg Scheuermann; Dario Neri
Drug discovery with DNA-encoded chemical libraries.
Bioconjugate chemistry 2010;21(9):1571-80.
2010: Verena Strassberger; Tim Fugmann; Dario Neri; Christoph Roesli
Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer.
Journal of proteomics 2010;73(10):1954-73.
2010: M Pedretti; C Verpelli; J Mårlind; G Bertani; C Sala; Dario Neri; L Bello
Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma.
British journal of cancer 2010;103(6):827-36.
2010: Roberto Sommavilla; Nadine Pasche; Eveline Trachsel; Leonardo Giovannoni; Christoph Roesli; Alessandra Villa; Dario Neri; Manuela Kaspar
Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.
Protein engineering, design & selection : PEDS 2010;23(8):653-61.
2010: Stefanie Pfaffen; Katharina Frey; Irène Stutz; Christoph Roesli; Dario Neri
Tumour-targeting properties of antibodies specific to MMP-1A, MMP-2 and MMP-3.
European journal of nuclear medicine and molecular imaging 2010;37(8):1559-65.
2010: Fabian Buller; Martina Steiner; Jörg Scheuermann; Luca Mannocci; Ina Nissen; Manuel Kohler; Christian Beisel; Dario Neri
High-throughput sequencing for the identification of binding molecules from DNA-encoded chemical libraries.
Bioorganic & medicinal chemistry letters 2010;20(14):4188-92.
2010: Tim Fugmann; Dario Neri; Christoph Roesli
DeepQuanTR: MALDI-MS-based label-free quantification of proteins in complex biological samples.
Proteomics 2010;10(14):2631-43.
2010: Jörg Scheuermann; Dario Neri
DNA-encoded chemical libraries: a tool for drug discovery and for chemical biology.
Chembiochem : a European journal of chemical biology 2010;11(7):931-7.
2010: Samu Melkko; Luca Mannocci; Christoph E Dumelin; Alessandra Villa; Roberto Sommavilla; Yixin Zhang; Markus G Grütter; Nadine Keller; Lutz Jermutus; R H Jackson; Jörg Scheuermann; Dario Neri
Isolation of a small-molecule inhibitor of the antiapoptotic protein Bcl-xL from a DNA-encoded chemical library.
ChemMedChem 2010;5(4):584-90.
2010: Flavio Schwarz; Wei Huang; Cishan Li; Benjamin L Schulz; Christian Lizak; Alessandro Palumbo; Shin Numao; Dario Neri; Markus Aebi; Lai-Xi Wang
A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation.
Nature chemical biology 2010;6(4):264-6.
2010: David Sgier; Kathrin Zuberbuehler; Stefanie Pfaffen; Dario Neri
Isolation and characterization of an inhibitory human monoclonal antibody specific to the urokinase-type plasminogen activator, uPA.
Protein engineering, design & selection : PEDS 2010;23(4):261-9.
2010: Stefanie Pfaffen; Teresa Hemmerle; Marcel Weber; Dario Neri
Isolation and characterization of human monoclonal antibodies specific to MMP-1A, MMP-2 and MMP-3.
Experimental cell research 2010;316(5):836-47.
2010: R Sommavilla; V Lovato; A Villa; D Sgier; Dario Neri
Design and construction of a naïve mouse antibody phage display library.
Journal of immunological methods 2010;353(1-2):31-43.
2010: Marta Pedretti; Zoran Rancic; Alex Soltermann; Bernhard A Herzog; Christoph Schliemann; Mario Lachat; Dario Neri; Philipp A Kaufmann
Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies.
Atherosclerosis 2010;208(2):382-9.
2010: Christoph Schliemann; Christoph Roesli; Haruhiko Kamada; Beatrice Borgia; Tim Fugmann; Wolfram Klapper; Dario Neri
In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.
Blood 2010;115(3):736-44.
2010: Matthias Rinderknecht; Alessandra Villa; Kurt Ballmer-Hofer; Dario Neri; Michael Detmar
Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.
PloS one 2010;5(8):e11941.
2010: Beatrice Borgia; Christoph Roesli; Tim Fugmann; Christoph Schliemann; Marta Cesca; Dario Neri; Raffaella Giavazzi
A proteomic approach for the identification of vascular markers of liver metastasis.
Cancer research 2010;70(1):309-18.
2009: Sabrina Trüssel; Christoph Dumelin; Katharina Frey; Alessandra Villa; Fabian Buller; Dario Neri
New strategy for the extension of the serum half-life of antibody fragments.
Bioconjugate chemistry 2009;20(12):2286-92.
2009: Christoph Schliemann; Andrea Wiedmer; Marta Pedretti; Monika Szczepanowski; Wolfram Klapper; Dario Neri
Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma.
Leukemia research 2009;33(12):1718-22.
2009: Fabian Buller; Yixin Zhang; Jörg Scheuermann; Juliane Schäfer; Peter Bühlmann; Dario Neri
Discovery of TNF inhibitors from a DNA-encoded chemical library based on diels-alder cycloaddition.
Chemistry & biology 2009;16(10):1075-86.
2009: J K J Ahlskog; C Schliemann; J Mårlind; U Qureshi; A Ammar; R B Pedley; Dario Neri
Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.
British journal of cancer 2009;101(4):645-57.
2009: Julia K J Ahlskog; Christoph E Dumelin; Sabrina Trüssel; Jessica Mårlind; Dario Neri
In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives.
Bioorganic & medicinal chemistry letters 2009;19(16):4851-6.
2009: Bernard M Tijink; Lars R Perk; Marianne Budde; Marijke Stigter-van Walsum; Gerard W M Visser; Reina W Kloet; Ludger M Dinkelborg; René Leemans; Dario Neri; Guus A M S van Dongen
(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.
European journal of nuclear medicine and molecular imaging 2009;36(8):1235-44.
2009: Christoph Roesli; Beatrice Borgia; Christoph Schliemann; Maja Gunthert; Heidi Wunderli-Allenspach; Raffaella Giavazzi; Dario Neri
Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.
Cancer research 2009;69(13):5406-14.
2009: Karl-Heinz Altmann; Dario Neri
Next generation therapeutics.
Current opinion in chemical biology 2009;13(3):231-4.
2009: Marta Pedretti; Alex Soltermann; Stephan Arni; Walter Weder; Dario Neri; Sven Hillinger
Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer.
Lung cancer (Amsterdam, Netherlands) 2009;64(1):28-33.
2009: Christoph Schliemann; Alessandro Palumbo; Kathrin Zuberbühler; Alessandra Villa; Manuela Kaspar; Eveline Trachsel; Wolfram Klapper; Hans Dietrich Menssen; Dario Neri
Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.
Blood 2009;113(10):2275-83.
2009: Kathrin Zuberbühler; Alessandro Palumbo; Camilla Bacci; Leonardo Giovannoni; Roberto Sommavilla; Manuela Kaspar; Eveline Trachsel; Dario Neri
A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells.
Protein engineering, design & selection : PEDS 2009;22(3):169-74.
2009: Haruhiko Kamada; Tim Fugmann; Dario Neri; Christoph Roesli
Improved protein sequence coverage by on resin deglycosylation and cysteine modification for biomarker discovery.
Proteomics 2009;9(3):783-7.
2009: Kathrin Schwager; Manuela Kaspar; Frank Bootz; Roberto Marcolongo; Erberto Paresce; Dario Neri; Eveline Trachsel
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis.
Arthritis research & therapy 2009;11(5):R142.
2008: Luca Mannocci; Yixin Zhang; Jörg Scheuermann; Markus Leimbacher; De Bellis Gianluca; Ermanno Rizzi; Christoph Dumelin; Samu Melkko; Dario Neri
High-throughput sequencing allows the identification of binding molecules isolated from DNA-encoded chemical libraries.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(46):17670-5.
2008: Fabian Buller; Luca Mannocci; Yixin Zhang; Christoph E Dumelin; Jörg Scheuermann; Dario Neri
Design and synthesis of a novel DNA-encoded chemical library using Diels-Alder cycloadditions.
Bioorganic & medicinal chemistry letters 2008;18(22):5926-31.
2008: Jessica Mårlind; Manuela Kaspar; Eveline Trachsel; Roberto Sommavilla; Stuart Hindle; Camilla Bacci; Leonardo Giovannoni; Dario Neri
Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6515-24.
2008: Alessandra Villa; Eveline Trachsel; Manuela Kaspar; Christoph Schliemann; Roberto Sommavilla; Jascha-N Rybak; Christoph Roesli; Laura Borsi; Dario Neri
A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.
International journal of cancer. Journal international du cancer 2008;122(11):2405-13.
2008: Christoph Roesli; Viviane Mumprecht; Dario Neri; Michael Detmar
Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(6):1933-44.
2008: C Avignolo; L Bagnasco; Barbara Biasotti; A Melchiori; V Tomati; I Bauer; Annalisa Salis; Laura Chiossone; M C Mingari; Paola Orecchia; Barbara Carnemolla; Dario Neri; Luciano Zardi; Stefano Parodi
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(4):1237-45.
2008: Jörg Scheuermann; Christoph E Dumelin; Samu Melkko; Yixin Zhang; Luca Mannocci; Madalina Jaggi; Jens Sobek; Dario Neri
DNA-encoded chemical libraries for the discovery of MMP-3 inhibitors.
Bioconjugate chemistry 2008;19(3):778-85.
2008: Christoph E Dumelin; Sabrina Trüssel; Fabian Buller; Eveline Trachsel; Frank Bootz; Yixin Zhang; Luca Mannocci; Susanne C Beck; Mihaela Drumea-Mirancea; Mathias W Seeliger; Christof Baltes; Thomas Müggler; Felicitas Kranz; Markus Rudin; Samu Melkko; Jörg Scheuermann; Dario Neri
A portable albumin binder from a DNA-encoded chemical library.
Angewandte Chemie (International ed. in English) 2008;47(17):3196-201.
2008: Christoph Roesli; Rybak Jascha; Dario Neri; Giuliano Elia
Quantitative recovery of biotinylated proteins from streptavidin-based affinity chromatography resins.
Methods in molecular biology (Clifton, N.J.) 2008;418():89-100.
2007: Valeria Lovato; Christoph Roesli; J Ahlskog; Jörg Scheuermann; Dario Neri
A monoclonal antibody prevents aggregation of the NBD1 domain of the cystic fibrosis transmembrane conductance regulator.
Protein engineering, design & selection : PEDS 2007;20(12):607-14.
2007: Christoph Schliemann; Dario Neri
Antibody-based targeting of the tumor vasculature.
Biochimica et biophysica acta 2007;1776(2):175-92.
2007: Rybak Jascha; Christoph Roesli; Manuela Kaspar; Alessandra Villa; Dario Neri
The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.
Cancer research 2007;67(22):10948-57.
2007: Samu Melkko; Christoph E Dumelin; Jörg Scheuermann; Dario Neri
Lead discovery by DNA-encoded chemical libraries.
Drug discovery today 2007;12(11-12):465-71.
2007: Manuela Kaspar; Eveline Trachsel; Dario Neri
The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
Cancer research 2007;67(10):4940-8.
2007: Manfred T Birchler; Christina Thuerl; Daniel Schmid; Dario Neri; Robert Waibel; August P Schubiger; Sandro J Stoeckli; Stephen Schmid; Gerhard W Goerres
Immunoscintigraphy of patients with head and neck carcinomas, with an anti-angiogenetic antibody fragment.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2007;136(4):543-8.
2007: Matthias T Wyss; Nicolas Spaeth; Gregoire Biollaz; Jens Pahnke; Patrizia Alessi; Eveline Trachsel; Valerie Treyer; Bruno Weber; Dario Neri; Alfred Buck
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):608-14.
2007: Tobias von Lukowicz; Michela Silacci; Matthias T Wyss; Eveline Trachsel; Christine Lohmann; Alfred Buck; Thomas F Lüscher; Dario Neri; Christian M Matter
Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):582-7.
2007: Vincent Castronovo; Philippe Kischel; francois guillonneau; Laurence de Leval; Thierry Deféchereux; Edwin De Pauw; Dario Neri; David Waltregny
Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.
Proteomics 2007;7(8):1188-96.
2007: Eveline Trachsel; Manuela Kaspar; Frank Bootz; Michael Detmar; Dario Neri
A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo.
The Journal of investigative dermatology 2007;127(4):881-6.
2007: Dragan Grabulovski; Manuela Kaspar; Dario Neri
A novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting properties.
The Journal of biological chemistry 2007;282(5):3196-204.
2007: Julian Bertschinger; Dragan Grabulovski; Dario Neri
Selection of single domain binding proteins by covalent DNA display.
Protein engineering, design & selection : PEDS 2007;20(2):57-68.
2007: Samu Melkko; Yixin Zhang; Christoph E Dumelin; Jörg Scheuermann; Dario Neri
Isolation of high-affinity trypsin inhibitors from a DNA-encoded chemical library.
Angewandte Chemie (International ed. in English) 2007;46(25):4671-4.
2007: Eveline Trachsel; Frank Bootz; Michela Silacci; Manuela Kaspar; Hartwig Kosmehl; Dario Neri
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.
Arthritis research & therapy 2007;9(1):R9.
2007: Jascha-N Rybak; Eveline Trachsel; Jörg Scheuermann; Dario Neri
Ligand-based vascular targeting of disease.
ChemMedChem 2007;2(1):22-40.
2006: Jörg Scheuermann; Christoph E Dumelin; Samu Melkko; Dario Neri
DNA-encoded chemical libraries.
Journal of biotechnology 2006;126(4):568-81.
2006: Vincent Castronovo; David Waltregny; Philippe Kischel; Christoph Roesli; Giuliano Elia; Rybak Jascha; Dario Neri
A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer.
Molecular & cellular proteomics : MCP 2006;5(11):2083-91.
2006: Verena Gafner; Eveline Trachsel; Dario Neri
An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties.
International journal of cancer. Journal international du cancer 2006;119(9):2205-12.
2006: Dietmar Berndorff; Sandra Borkowski; Dieter Moosmayer; Francesca Viti; Beate Müller-Tiemann; Stephanie Sieger; Matthias Friebe; Christoph S Hilger; Luciano Zardi; Dario Neri; Ludger M Dinkelborg
Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1707-16.
2006: Michela Silacci; Simon S Brack; Nicolas Späth; Alfred Buck; Sven Hillinger; Stephan Arni; Walter Weder; Luciano Zardi; Dario Neri
Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo.
Protein engineering, design & selection : PEDS 2006;19(10):471-8.
2006: Eveline Trachsel; Dario Neri
Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis.
Advanced drug delivery reviews 2006;58(5-6):735-54.
2006: Anna Ettorre; Christoph Roesli; Michela Silacci; Simon S Brack; Gregor McCombie; Richard Knochenmuss; Giuliano Elia; Dario Neri
Recombinant antibodies for the depletion of abundant proteins from human serum.
Proteomics 2006;6(16):4496-505.
2006: Alexander Berndt; Katharina Anger; Petra Richter; Laura Borsi; Simon S Brack; Michela Silacci; Marcus Franz; Heiko Wunderlich; Mieczyslaw Gajda; Luciano Zardi; Dario Neri; Hartwig Kosmehl
Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.
Journal of cancer research and clinical oncology 2006;132(8):537-46.
2006: Nicolas Spaeth; Matthias T Wyss; Jens Pahnke; Gregoire Biollaz; Eveline Trachsel; Konstantin Drandarov; Valerie Treyer; Bruno Weber; Dario Neri; Alfred Buck
Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19).
Nuclear medicine and biology 2006;33(5):661-6.
2006: Bernard M Tijink; Dario Neri; René Leemans; Marianne Budde; Ludger M Dinkelborg; Marijke Stigter-van Walsum; Luciano Zardi; Guus A M S van Dongen
Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(7):1127-35.
2006: Simon S Brack; Michela Silacci; Manfred Birchler; Dario Neri
Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3200-8.
2006: Enrica Balza; Lorenzo Mortara; Francesca Sassi; Stefano Monteghirfo; Barbara Carnemolla; Patrizia Castellani; Dario Neri; Roberto Accolla; Luciano Zardi; Laura Borsi
Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2575-82.
2006: Monica Fabbrini; Eveline Trachsel; Patrizia Soldani; Stefano Bindi; Patrizia Alessi; Luisa Bracci; Hartwig Kosmehl; Luciano Zardi; Dario Neri; Paolo Neri
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.
International journal of cancer. Journal international du cancer 2006;118(7):1805-13.
2006: Manuela Kaspar; Luciano Zardi; Dario Neri
Fibronectin as target for tumor therapy.
International journal of cancer. Journal international du cancer 2006;118(6):1331-9.
2006: Christoph E Dumelin; Jörg Scheuermann; Samu Melkko; Dario Neri
Selection of streptavidin binders from a DNA-encoded chemical library.
Bioconjugate chemistry 2006;17(2):366-70.
2006: Dario Neri; Giacomo Fossati; Matteo Zanda
Efforts toward the total synthesis of tubulysins: new hopes for a more effective targeted drug delivery to tumors.
ChemMedChem 2006;1(2):175-80.
2006: Samu Melkko; Christoph E Dumelin; Jörg Scheuermann; Dario Neri
On the magnitude of the chelate effect for the recognition of proteins by pharmacophores scaffolded by self-assembling oligonucleotides.
Chemistry & biology 2006;13(2):225-31.
2006: Christoph Roesli; Giuliano Elia; Dario Neri
Two-dimensional mass spectrometric mapping.
Current opinion in chemical biology 2006;10(1):35-41.
2006: Christoph Roesli; Dario Neri; Rybak Jascha
In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature.
Nature protocols 2006;1(1):192-9.
2005: Christina Ebbinghaus; Roberto Ronca; Manuela Kaspar; Dragan Grabulovski; Alexander Berndt; Hartwig Kosmehl; Luciano Zardi; Dario Neri
Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.
International journal of cancer. Journal international du cancer 2005;116(2):304-13.
2005: Simone B Scheurer; Christoph Roesli; Dario Neri; Giuliano Elia
A comparison of different biotinylation reagents, tryptic digestion procedures, and mass spectrometric techniques for 2-D peptide mapping of membrane proteins.
Proteomics 2005;5(12):3035-9.
2005: Simone B Scheurer; Rybak Jascha; Christoph Roesli; René Brunisholz; Frank Potthast; Ralph Schlapbach; Dario Neri; Giuliano Elia
Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping.
Proteomics 2005;5(11):2718-28.
2005: Dario Neri; Roy Bicknell
Tumour vascular targeting.
Nature reviews. Cancer 2005;5(6):436-46.
2005: Michela Silacci; Simon S Brack; Giulia Schirru; Jessica Mårlind; Anna Ettorre; Adrian Merlo; Francesca Viti; Dario Neri
Design, construction, and characterization of a large synthetic human antibody phage display library.
Proteomics 2005;5(9):2340-50.
2005: Rybak Jascha; Anna Ettorre; Brigitte Kaissling; Raffaella Giavazzi; Dario Neri; Giuliano Elia
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature.
Nature methods 2005;2(4):291-8.
2004: Christian M Matter; Pia K Schuler; Patrizia Alessi; Patricia Meier; Romeo Ricci; Dongming Zhang; Cornelia Halin; Patrizia Castellani; Luciano Zardi; Christoph Hofer; matteo montani; Dario Neri; Thomas F Lüscher
Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.
Circulation research 2004;95(12):1225-33.
2004: Julian Bertschinger; Dario Neri
Covalent DNA display as a novel tool for directed evolution of proteins in vitro.
Protein engineering, design & selection : PEDS 2004;17(9):699-707.
2004: Simon S Brack; Ludger M Dinkelborg; Dario Neri
Molecular targeting of angiogenesis for imaging and therapy.
European journal of nuclear medicine and molecular imaging 2004;31(9):1327-41.
2004: Rybak Jascha; Simone B Scheurer; Dario Neri; Giuliano Elia
Purification of biotinylated proteins on streptavidin resin: a protocol for quantitative elution.
Proteomics 2004;4(8):2296-9.
2004: Simone B Scheurer; Rybak Jascha; Christoph Roesli; Dario Neri; Giuliano Elia
Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study.
Proteomics 2004;4(6):1737-60.
2004: Christian Heinis; Patrizia Alessi; Dario Neri
Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy.
Biochemistry 2004;43(20):6293-303.
2004: Samu Melkko; Jörg Scheuermann; Christoph E Dumelin; Dario Neri
Encoded self-assembling chemical libraries.
Nature biotechnology 2004;22(5):568-74.
2004: Patrizia Alessi; Christina Ebbinghaus; Dario Neri
Molecular targeting of angiogenesis.
Biochimica et biophysica acta 2004;1654(1):39-49.
2004: Christina Ebbinghaus; Jörg Scheuermann; Dario Neri; Giuliano Elia
Diagnostic and therapeutic applications of recombinant antibodies: targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis.
Current pharmaceutical design 2004;10(13):1537-49.
2003: Laura Borsi; Enrica Balza; Barbara Carnemolla; Francesca Sassi; Patrizia Castellani; Alexander Berndt; Hartwig Kosmehl; Attila Biro; Annalisa Siri; Paola Orecchia; Jessica Grassi; Dario Neri; Luciano Zardi
Selective targeted delivery of TNFalpha to tumor blood vessels.
Blood 2003;102(13):4384-92.
2003: T A Afanasieva; M Wittmer; A Vitaliti; M Ajmo; Dario Neri; R Klemenz
Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.
Gene therapy 2003;10(21):1850-9.
2003: Manfred T Birchler; Dusan Milisavlijevic; Madeleine Pfaltz; Dario Neri; Bernhard Odermatt; Stefan Schmid; Sandro J Stoeckli
Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors.
The Laryngoscope 2003;113(7):1231-7.
2003: Cornelia Halin; Verena Gafner; Maria Elena Villani; Laura Borsi; Alexander Berndt; Hartwig Kosmehl; Luciano Zardi; Dario Neri
Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
Cancer research 2003;63(12):3202-10.
2003: Maja A Bumke; Dario Neri; Giuliano Elia
Modulation of gene expression by extracellular pH variations in human fibroblasts: a transcriptomic and proteomic study.
Proteomics 2003;3(5):675-88.
2003: Jörg Scheuermann; Francesca Viti; Dario Neri
Unexpected observation of concentration-dependent dissociation rates for antibody-antigen complexes and other macromolecular complexes in competition experiments.
Journal of immunological methods 2003;276(1-2):129-34.
2003: Monica Santimaria; Giovanni Moscatelli; Giuseppe L Viale; Leonardo Giovannoni; Giovanni Neri; Francesca Viti; Alessandra Leprini; Laura Borsi; Patrizia Castellani; Luciano Zardi; Dario Neri; Pietro Riva
Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):571-9.
2003: Dario Neri
Targeting the vascular endothelium--novel approaches.
Pathophysiology of haemostasis and thrombosis 2003;33 Suppl 1():7-8.
2003: Christian Heinis; Julian Bertschinger; Dario Neri
Calmodulin-tagged phage and two-filter sandwich assays for the identification of enzymatic activities.
Methods in molecular biology (Clifton, N.J.) 2003;230():313-28.
2003: Massimo Nicolò; Attila Birò; Felice Cardillo-Piccolino; Patrizia Castellani; Alfonso Giovannini; Cesare Mariotti; Mario Zingirian; Dario Neri; Luciano Zardi
Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes.
American journal of ophthalmology 2003;135(1):7-13.
2003: Samu Melkko; Dario Neri
Calmodulin as an affinity purification tag.
Methods in molecular biology (Clifton, N.J.) 2003;205():69-77.
2002: Giuliano Elia; Michela Silacci; Simone Scheurer; Jörg Scheuermann; Dario Neri
Affinity-capture reagents for protein arrays.
Trends in biotechnology 2002;20(12 Suppl):S19-22.
2002: Samu Melkko; Cornelia Halin; Laura Borsi; Luciano Zardi; Dario Neri
An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.
International journal of radiation oncology, biology, physics 2002;54(5):1485-90.
2002: Cornelia Halin; Uwe Niesner; Maria Elena Villani; Luciano Zardi; Dario Neri
Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins.
International journal of cancer. Journal international du cancer 2002;102(2):109-16.
2002: Patrizia Castellani; Laura Borsi; Barbara Carnemolla; Attila Birò; Alessandra Dorcaratto; Giuseppe L Viale; Dario Neri; Luciano Zardi
Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin.
The American journal of pathology 2002;161(5):1695-700.
2002: Laura Borsi; Enrica Balza; Marco Bestagno; Patrizia Castellani; Barbara Carnemolla; Attila Biro; Alessandra Leprini; Jorge Sepulveda; Oscar R. Burrone; Dario Neri; Luciano Zardi
Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin.
International journal of cancer. Journal international du cancer 2002;102(1):75-85.
2002: Uwe Niesner; Cornelia Halin; Luisa Lozzi; Maja Günthert; Paolo Neri; Heidi Wunderli-Allenspach; Luciano Zardi; Dario Neri
Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides.
Bioconjugate chemistry 2002;13(4):729-36.
2002: Cornelia Marty; Bernhard Odermatt; Herbert Schott; Dario Neri; Kurt Ballmer-Hofer; R Klemenz; Reto Schwendener
Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes.
British journal of cancer 2002;87(1):106-12.
2002: Christian Heinis; Samu Melkko; Salvatore Demartis; Dario Neri
Two general methods for the isolation of enzyme activities by colony filter screening.
Chemistry & biology 2002;9(3):383-90.
2002: Francesca Viti; Leonardo Giovannoni; Dario Neri
Recombinant antibodies for the selective targeting of tumor neovasculature.
Current opinion in drug discovery & development 2002;5(2):204-13.
2002: Cornelia Halin; S Rondini; F Nilsson; Alexander Berndt; Hartwig Kosmehl; Luciano Zardi; Dario Neri
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.
Nature biotechnology 2002;20(3):264-9.
2002: Barbara Carnemolla; Laura Borsi; Enrica Balza; Patrizia Castellani; Raffaella Meazza; Alexander Berndt; Silvano Ferrini; Hartwig Kosmehl; Dario Neri; Luciano Zardi
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.
Blood 2002;99(5):1659-65.
2001: Christian Heinis; A Huber; Salvatore Demartis; J Bertschinger; Samu Melkko; Luisa Lozzi; Paolo Neri; Dario Neri
Selection of catalytically active biotin ligase and trypsin mutants by phage display.
Protein engineering 2001;14(12):1043-52.
2001: Laura Borsi; Barbara Carnemolla; Dario Neri; Luciano Zardi
Use of human recombinant antibodies to the marker of angiogenesis ed-b in cancer therapy.
Tumori 2001;87(6):S8-10.
2001: Enrica Balza; Patrizia Castellani; A Zijlstra; Dario Neri; Luciano Zardi; Annalisa Siri
Lack of specificity of endoglin expression for tumor blood vessels.
International journal of cancer. Journal international du cancer 2001;94(4):579-85.
2001: Cornelia Halin; Luciano Zardi; Dario Neri
Antibody-based targeting of angiogenesis.
News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society 2001;16():191-4.
2001: Salvatore Demartis; L Tarli; Laura Borsi; Luciano Zardi; Dario Neri
Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin.
European journal of nuclear medicine 2001;28(4):534-9.
2001: Leonardo Giovannoni; Francesca Viti; Luciano Zardi; Dario Neri
Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening.
Nucleic acids research 2001;29(5):E27.
2001: F Nilsson; Hartwig Kosmehl; Luciano Zardi; Dario Neri
Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.
Cancer research 2001;61(2):711-6.
2001: Dario Neri
Targeted delivery of tissue factor to tumor neovasculature for cancer therapy.
Haemostasis 2001;31 Suppl 1():21-2.
2001: Cornelia Halin; Dario Neri
Antibody-Based targeting of angiogenesis.
Critical reviews in therapeutic drug carrier systems 2001;18(3):299-339.
2000: F Nilsson; L Tarli; Francesca Viti; Dario Neri
The use of phage display for the development of tumour targeting agents.
Advanced drug delivery reviews 2000;43(2-3):165-96.
2000: A Vitaliti; M Wittmer; R Steiner; L Wyder; Dario Neri; R Klemenz
Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor.
Cancer research 2000;60(16):4311-4.
2000: Leonardo Giovannoni; Luisa Lozzi; Dario Neri; Paolo Neri
Highly fluorescent protein labeling using dendritic peptide derivatives.
The journal of peptide research : official journal of the American Peptide Society 2000;55(3):195-202.
2000: Francesca Viti; F Nilsson; Salvatore Demartis; A Huber; Dario Neri
Design and use of phage display libraries for the selection of antibodies and enzymes.
Methods in enzymology 2000;326():480-505.
1999: Manfred Birchler; G Neri; L Tarli; Cornelia Halin; Francesca Viti; Dario Neri
Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers.
Journal of immunological methods 1999;231(1-2):239-48.
1999: Manfred Birchler; Francesca Viti; Luciano Zardi; B Spiess; Dario Neri
Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment.
Nature biotechnology 1999;17(10):984-8.
1999: L Tarli; Enrica Balza; Francesca Viti; Laura Borsi; Patrizia Castellani; Dietmar Berndorff; Ludger M Dinkelborg; Dario Neri; Luciano Zardi
A high-affinity human antibody that targets tumoral blood vessels.
Blood 1999;94(1):192-8.
1999: A Huber; Salvatore Demartis; Dario Neri
The use of biosensor technology for the engineering of antibodies and enzymes.
Journal of molecular recognition : JMR 1999;12(3):198-216.
1999: Barbara Carnemolla; Patrizia Castellani; Marco Ponassi; Laura Borsi; S Urbini; G Nicolo; Alessandra Dorcaratto; Giuseppe L Viale; G Winter; Dario Neri; Luciano Zardi
Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody.
The American journal of pathology 1999;154(5):1345-52.
1999: Roberto Fattorusso; M Pellecchia; Francesca Viti; Paolo Neri; Dario Neri; Kurt Wüthrich
NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis.
Structure (London, England : 1993) 1999;7(4):381-90.
1999: Salvatore Demartis; A Huber; Francesca Viti; Luisa Lozzi; Leonardo Giovannoni; Paolo Neri; G Winter; Dario Neri
A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage.
Journal of molecular biology 1999;286(2):617-33.
1999: P M Kirkham; Dario Neri; G Winter
Towards the design of an antibody that recognises a given protein epitope.
Journal of molecular biology 1999;285(3):909-15.
1999: Francesca Viti; L Tarli; Leonardo Giovannoni; Luciano Zardi; Dario Neri
Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.
Cancer research 1999;59(2):347-52.
1998: Alessandro Pini; Francesca Viti; A Santucci; Barbara Carnemolla; Luciano Zardi; Paolo Neri; Dario Neri
Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.
The Journal of biological chemistry 1998;273(34):21769-76.
1998: Laura Borsi; Patrizia Castellani; G Allemanni; Dario Neri; Luciano Zardi
Preparation of phage antibodies to the ED-A domain of human fibronectin.
Experimental cell research 1998;240(2):244-51.
1998: Dario Neri; Alessandro Pini; A Nissim
Antibodies from phage display libraries as immunochemical reagents.
Methods in molecular biology (Clifton, N.J.) 1998;80():475-500.
1997: G Mariani; A Lasku; Enrica Balza; B Gaggero; C Motta; L Di Luca; Alessandra Dorcaratto; Giuseppe Viale; Dario Neri; Luciano Zardi
Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants.
Cancer 1997;80(12 Suppl):2378-84.
1997: Dario Neri; Barbara Carnemolla; A Nissim; Alessandra Leprini; G Querzè; Enrica Balza; Alessandro Pini; L Tarli; Cornelia Halin; Paolo Neri; Luciano Zardi; G Winter
Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.
Nature biotechnology 1997;15(12):1271-5.
1997: Alessandro Pini; Adriano Spreafico; R Botti; Dario Neri; Paolo Neri
Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma.
Journal of immunological methods 1997;206(1-2):171-82.
1996: Dario Neri; S Montigiani; P M Kirkham
Biophysical methods for the determination of antibody-antigen affinities.
Trends in biotechnology 1996;14(12):465-70.
1996: Barbara Carnemolla; Dario Neri; Patrizia Castellani; Alessandra Leprini; G Neri; Alessandro Pini; G Winter; Luciano Zardi
Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain.
International journal of cancer. Journal international du cancer 1996;68(3):397-405.
1996: Dario Neri; Pier Giorgio Natali; H Petrul; P Soldani; M R Nicotra; R Vola; A Rivella; A M Creighton; P Neri; M Mariani
Recombinant anti-human melanoma antibodies are versatile molecules.
The Journal of investigative dermatology 1996;107(2):164-70.
1996: S Montigiani; G Neri; Paolo Neri; Dario Neri
Alanine substitutions in calmodulin-binding peptides result in unexpected affinity enhancement.
Journal of molecular biology 1996;258(1):6-13.
1996: Dario Neri; H Petrul; G Winter; Yvonne Light; Richard Marais; K E Britton; A M Creighton
Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP.
Nature biotechnology 1996;14(4):485-90.
1996: Dario Neri; T Prospero; H Petrul; G Winter; M Browne; L Vanderpant
Multipurpose high sensitivity luminescence analyzer (LUANA): use in gel electrophoresis.
BioTechniques 1996;20(4):708-13.
1995: Mauro Liberatore; Dario Neri; G Neri; Alessandro Pini; Anna Paola Iurilli; Fabio Ponzo; G Spampinato; F Padula; Alessandro Pala; AC Colella
Efficient one-step direct labelling of recombinant antibodies with technetium-99m.
European journal of nuclear medicine 1995;22(11):1326-9.
1995: Dario Neri; H Petrul; G Roncucci
Engineering recombinant antibodies for immunotherapy.
Cell biophysics 1995;27(1):47-61.
1995: Dario Neri; C de Lalla; H Petrul; P Neri; G Winter
Calmodulin as a versatile tag for antibody fragments.
Bio/technology (Nature Publishing Company) 1995;13(4):373-7.
1995: Dario Neri; M Momo; T Prospero; G Winter
High-affinity antigen binding by chelating recombinant antibodies (CRAbs).
Journal of molecular biology 1995;246(3):367-73.
1994: R Vola; A Lombardi; L Tarditi; M Zaccolo; Dario Neri; L Björck; M Mariani
Recombinant proteins L and LG. Two new tools for purification of murine antibody fragments.
Cell biophysics 1994;24-25():27-36.